Cargando…

Smac/DIABLO expression in human gastrointestinal carcinoma: Association with clinicopathological parameters and survivin expression

Lack of apoptosis is a key factor in carcinogenesis and tumor progression. Survivin is a member of the inhibitor of apoptosis protein (IAP) family. Second mitochondria-derived activator of caspases/direct inhibitor of apoptosis-binding protein with low pI (Smac/DIABLO) is an antagonist of IAPs. Rece...

Descripción completa

Detalles Bibliográficos
Autores principales:	SHINTANI, MICHIKO, SANGAWA, AKIKO, YAMAO, NAOKI, KAMOSHIDA, SHINGO
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214500/ https://www.ncbi.nlm.nih.gov/pubmed/25364431 http://dx.doi.org/10.3892/ol.2014.2598

Ejemplares similares

Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma
por: Dobrzycka, Bozena, et al.
Publicado: (2015)

Role of Smac/DIABLO in cancer progression
por: Martinez-Ruiz, Gustavo, et al.
Publicado: (2008)

High Smac/DIABLO expression is associated with early local recurrence of cervical cancer
por: Arellano-Llamas, Abril, et al.
Publicado: (2006)

Disturbed balance of expression between XIAP and Smac/DIABLO during tumour progression in renal cell carcinomas
por: Yan, Y, et al.
Publicado: (2004)

Novel link between E2F1 and Smac/DIABLO: proapoptotic Smac/DIABLO is transcriptionally upregulated by E2F1
por: Xie, Wei, et al.
Publicado: (2006)

Effects of Fluid Shear Stress on Expression of Smac/DIABLO in Human Umbilical Vein Endothelial Cells()
por: Zhang, Feng, et al.
Publicado: (2013)

Potency and Selectivity of SMAC/DIABLO Mimetics in Solid Tumor Therapy
por: Zhao, Xiao-Yun, et al.
Publicado: (2020)

SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesis
por: Pandey, Swaroop Kumar, et al.
Publicado: (2021)

Expression of Survivin and Cortactin in Colorectal Adenocarcinoma: Association with Clinicopathological Parameters
por: Lee, Ying-Yu, et al.
Publicado: (2009)

Real-time single cell analysis of Smac/DIABLO release during apoptosis
por: Rehm, Markus, et al.
Publicado: (2003)

Opposite regulation of XIAP and Smac/DIABLO in the rat endometrium in response to 17β-estradiol at estrus
por: Leblanc, Valerie, et al.
Publicado: (2003)

Osmostress-Induced Apoptosis in Xenopus Oocytes: Role of Stress Protein Kinases, Calpains and Smac/DIABLO
por: Messaoud, Nabil Ben, et al.
Publicado: (2015)

MiR-24-BIM-Smac/DIABLO axis controls the sensitivity to doxorubicin treatment in osteosarcoma
por: Sun, Yangbai, et al.
Publicado: (2016)

CD56 and CD11b Positivity with Low Smac/DIABLO Expression as Predictors of Chemoresistance in Acute Myeloid Leukaemia: Flow Cytometric Analysis
por: Ibrahim, Abeer, et al.
Publicado: (2018)

The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein
por: Mariniello, Raffaela Mariarosaria, et al.
Publicado: (2020)

Smac/DIABLO enhances the therapeutic potential of chemotherapeutic drugs and irradiation, and sensitizes TRAIL-resistant breast cancer cells
por: Fandy, Tamer E, et al.
Publicado: (2008)

Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancer
por: MIZUTANI, YOICHI, et al.
Publicado: (2012)

Integrin-Targeting Dye-Doped PEG-Shell/Silica-Core Nanoparticles Mimicking the Proapoptotic Smac/DIABLO Protein
por: De Marco, Rossella, et al.
Publicado: (2020)

The role of NF-κB and Smac/DIABLO proteins in the treatment response and survival of acute myeloid leukemia patients
por: Pluta, Agnieszka, et al.
Publicado: (2019)

Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppression
por: Pandey, Swaroop Kumar, et al.
Publicado: (2022)

Application of Flow Cytometry to Determine Differential Redistribution of Cytochrome c and Smac/DIABLO from Mitochondria during Cell Death Signaling
por: Ng, Heling, et al.
Publicado: (2012)

Dual-targeting peptides@PMO, a mimetic to the pro-apoptotic protein Smac/DIABLO for selective activation of apoptosis in cancer cells
por: Di Giorgio, Eros, et al.
Publicado: (2023)

P62/Ubiquitin IHC Expression Correlated with Clinicopathologic Parameters and Outcome in Gastrointestinal Carcinomas
por: Mohamed, Amr, et al.
Publicado: (2015)

lncRNA TUG1 regulates Smac/DIABLO expression by competitively inhibiting miR-29b and modulates the apoptosis of lens epithelial cells in age-related cataracts
por: Sun, Miaomiao, et al.
Publicado: (2023)

Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Xie, Yongpeng, et al.
Publicado: (2016)

Clinicopathological and Prognostic Value of Survivin Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma
por: Vay, Christian, et al.
Publicado: (2022)

Development of a FACS-based Smac/DIABLO release assay to monitor individual drug responses and to pave the way towards patient-tailored therapies
por: Arora, Jigyasa, et al.
Publicado: (2015)

Effect of Src Kinase inhibition on Cytochrome c, Smac/DIABLO and Apoptosis Inducing Factor (AIF) Following Cerebral Hypoxia-Ischemia in Newborn Piglets
por: Kratimenos, Panagiotis, et al.
Publicado: (2017)

Clinicopathological and Prognostic Significance of Survivin Over-Expression in Patients with Esophageal Squamous Cell Carcinoma: A Meta-Analysis
por: Li, Chunguang, et al.
Publicado: (2012)

Expression of matrix metalloproteinase-2 and survivin in endometrioid and nonendometrioid endometrial cancers and clinicopathologic significance
por: Yilmaz, Evren, et al.
Publicado: (2011)

CD4+ T cell-mimicking nanoparticles encapsulating DIABLO/SMAC mimetics broadly neutralize HIV-1 and selectively kill HIV-1-infected cells
por: Campbell, Grant R., et al.
Publicado: (2021)

Survivin expression in oral squamous cell carcinoma
por: Muzio, L Lo, et al.
Publicado: (2003)

Clinicopathological and Prognostic Significance of Survivin Expression in Patients with Oral Squamous Cell Carcinoma: Evidence from a Meta-Analysis
por: Xie, Shang, et al.
Publicado: (2015)

Diablo guardián /
por: Velasco, Xavier
Publicado: (2004)

Santos diablos
por: Álvarez Contreras, Héctor
Publicado: (2003)

Diablo guardián /
por: Velasco, Xavier
Publicado: (2006)

Diablo guardián
por: Velasco, Xavier
Publicado: (2003)

El diablo /
por: Tsvirtáieva, Marina

El diablo /
por: Tolstoi, León, 1828-1910
Publicado: (1984)

Clinical Significance of Survivin Expression in Patients with Urothelial Carcinoma
por: Chen, Hsin-An, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_621bp8udr72aap63qk8j5mba5m